Stock Market Update: NRX Pharmaceuticals Surges and OneMain Beats Estimates

Stock market activity late in the week featured notable movements across multiple sectors, ranging from biotechnology and consumer finance to energy and aviation connectivity. Investors closely monitored corporate updates, regulatory milestones, and upcoming earnings announcements.

NRX Pharmaceuticals Inc. stock [NASDAQ: NRXP] surged significantly, trading up by 18.8 percent following positive trial developments and regulatory progress. The company received an FDA Discipline Review Letter for its preservative-free ketamine product, Ketafree, ahead of the November 10, 2026, GDUFA goal date. Management noted that only minor labeling changes were requested, indicating a favorable review process.

In addition to the regulatory milestone, NRx Pharmaceuticals completed three commercial-scale validation lots and demonstrated two-year room-temperature stability. The company is actively preparing for potential product shortages by pre-ordering 5 million doses. Furthermore, NRx Defense Systems secured an initial prime contract valued between approximately $11 million and $11.25 million from DARPA to fund the SPARC-TMS trial, pairing advanced transcranial magnetic stimulation with NRX-101 for treatment-resistant depression.

In the consumer finance sector, OneMain Holdings (NYSE: OMF) announced its third-quarter financial results for 2026, surpassing Wall Street expectations. The company reported a 7.3 percent year-over-year increase in revenue, reaching $1.36 billion. Net interest income climbed to $1.15 billion, exceeding consensus estimates.

OneMain also reported a GAAP profit of $1.60 per share, beating analysts' projections by 5.5 percent. Doug Shulman, Chairman and CEO of OneMain, attributed the strong quarter to sustained business momentum and rigorous credit discipline. Following the earnings release, company shares remained flat at $59.36.

Meanwhile, other corporations prepared for upcoming financial disclosures. SandRidge Energy, Inc. (NYSE: SD) announced that it will release its third-quarter 2026 operational and financial results after the market closes on Wednesday, November 4, 2026, followed by a conference call with investors on Thursday, November 5, 2026.

In corporate leadership developments, Gogo (NASDAQ: GOGO) appointed Amy Greene as Vice President of Investor Relations, Communications, and Government Affairs. Greene brings over twenty years of experience in the financial industry, having previously served in leadership roles at various corporate and wealth management entities.

Overall, market participants continued to evaluate a mix of regulatory catalysts, quarterly earnings reports, and executive appointments as companies navigate evolving economic conditions.